"Virginia Heart is the leader in cardiovascular care in the Washington D.C. metropolitan area and our patients have been putting their trust in us for over 30 years. Our Virginia Heart team of physicians and professionals is dedicated to providing the highest standards of care using the most advanced diagnostic procedures and treatments, ensuring our patients with the best possible outcomes and quality of life."

During the past decade, The Cardiovascular Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Cardiovascular Group" #1 collaborator was "Medtronic" with 1 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "The Cardiovascular Group" are "Heart Failure" (2 trials), "Coronary Artery Disease" (1 trials), "Heart Failure NYHA Class II" (1 trials), "Heart Failure NYHA Class III" (1 trials) and "Heart Failure NYHA Class IV" (1 trials). Many other conditions were trialed in "The Cardiovascular Group" in a lesser frequency.

Most popular intervention types in "The Cardiovascular Group" are "Device" (2 trials), "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "BiV/MPP" (1 trials), "CardioMEMS™ HF System" (1 trials), "EDTA" (1 trials), "EDTA Placebo" (1 trials) and "High Dose Vitamin" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Cardiovascular Group" are 5 trials for "All" genders.

Currently, there are NaN active trials in "The Cardiovascular Group". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in The Cardiovascular Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Cardiovascular Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

The Cardiovascular Group has several departments that took part in Clinical trials: "Virginia Heart" - 17 trials